Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 4/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | PPARG | P37231 | 3/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.58 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.58 |
| ▸ | RELA | Q04206 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | CNR1 | P21554 | 1/20 | 0.55 |
| ▸ | CNR2 | P34972 | 1/20 | 0.55 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4179938 | 0.90 | PPARA (0.62) | PPARAPPARGCYP2D6KMT2ACNR1 | |
| SCHEMBL13309866 | 0.90 | NPC1 (0.67) | NPC1LMNANFKB1NFKB2RELA | |
| SCHEMBL13309867 | 0.90 | NPC1 (0.67) | NPC1LMNANFKB1NFKB2RELA | |
| SCHEMBL303090 | 0.89 | LMNA (0.69) | NPC1LMNANFKB1NFKB2RELA | |
| SCHEMBL13038199 | 0.89 | LMNA (0.69) | NPC1LMNANFKB1NFKB2RELA | |
| SCHEMBL302600 | 0.89 | LMNA (0.69) | NPC1LMNANFKB1NFKB2RELA | |
| SCHEMBL10807628 | 0.87 | PPARA (0.64) | PPARAPPARGCNR1CNR2 | |
| SCHEMBL13038204 | 0.86 | RARB (0.64) | NPC1LMNANFKB1NFKB2RELA | |
| SCHEMBL9855583 | 0.86 | LMNA (0.69) | NPC1LMNANFKB1NFKB2RELA | |
| SCHEMBL21124189 | 0.86 | LMNA (0.69) | NPC1LMNANFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090143609-A1 | LIQUID CRYSTAL COMPOSITIONS AND THEIR USE IN LIQUID CRYSTAL DEVICES | IPS ALPHA SUPPORT CO., LTD. (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090143609-A1 | LIQUID CRYSTAL COMPOSITIONS AND THEIR USE IN LIQUID CRYSTAL DEVICES | IPS ALPHA SUPPORT CO., LTD. (JP) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143609-A1 | LIQUID CRYSTAL COMPOSITIONS AND THEIR USE IN LIQUID CRYSTAL DEVICES | GTF3C3, CCR3, OR10J3 | PPARA 4802/4885NPC1 2125/4885LMNA 2090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.